Home > Press/Media > Press releases > Archive
Archive: Press Releases
Use the links below to download all recent AFFiRiS press releases . Adobe Reader is needed to view them.
Press release: April 23, 2010
AFFiRiS AG: Alzheimer's vaccine AD02 already in clinical phase II
Press release: March 30, 2010
Parkinson vaccination: Good start to the spring for AFFiRiS AG
Press release: February 25, 2010
Vaccination against hypertension is development project No. 4 and has already been awarded a FFG grant of up to EUR 1.2 million
Press release: October 20, 2009
AFFiRiS AG – Encouraging Results from Phase I Studies of Two Alzheimer's Candidate Vaccines Trigger a EUR 10 Million Milestone Payment
Press release: May 27, 2009
AFFiRiS AG: Atherosclerosis Vaccine Development Receives EU Support
Press release: December 22, 2008
AFFiRiS begins development of a Parkinson's vaccine
Press release: October 23, 2008
GlaxoSmithKline and AFFiRiS sign an exclusive licence and option agreement for therapeutic Alzheimer’s disease candidate vaccines
Press release: July 16, 2008
AFFiRiS: Milestone Reached in Clinical Trial of Alzheimer’s Vaccine
Press release: April 28, 2008
AFFiRiS in Biotech Spotlight 2008 – Independent Analysis Confirms Global Potential of Company’s Technology
Press release: March 18, 2008
AFFiRiS Uses Definiens Technology in Fight Against Alzheimer’s Disease
Presse release: February 27, 2008
AFFiRiS Expands Patent Portfolio for Alzheimer’s Therapies
